Robotics Business Review

OCTOBER 19, 2024

The firm is led by two retinal surgeons and supports biotechnology, medical devices, pharmaceuticals, and software in ophthalmology. Later, he served on the Board of AMO’s successor company, Advanced Medical Optics (AMO), which was acquired by Abbott in 2009 and then by Johnson and Johnson in 2016. In addition, Firas M. Rahhal, M.D.,

Robotics 120

Robotics Robotics Artificial Intelligence Pharmaceutical 120

Canadian Manufacturing

OCTOBER 13, 2022

CERRITOS — Electrolit – a hydration beverage made from pharmaceutical grade ingredients – announces that Enrico De La Torre is the company’s new Commercial Director for the Canada office. Enrico De La Torre.

Beverage 52

Beverage Pharmaceutical Function Manufacturing 52

MEM

DECEMBER 15, 2022

All over the world precious bodies of water are contaminated with micropollutants such as pesticides, pharmaceuticals, and PFAS chemicals. was drastically lowered from 400 ppt (ng/L) in 2009 to 0.004 ppq (pg/L), a 100,000x stricter level due to the danger these chemicals pose to humans when consumed. from contaminated wastewater.

Pharmaceutical 52

Pharmaceutical Consumer Goods Value chain Sourcing 52

Canadian Manufacturing

AUGUST 17, 2022

Mr. Coutu has been with the company since 2009 after working in the industry for several years. Champagne has been involved in the combination of the Jean Coutu Group and METRO. METRO reports that though he leaves the pharmacy division, the banners and the pharmacists are well positioned for the future.

Pharmaceutical 40

Pharmaceutical Manufacturing 40

Foley

JULY 11, 2023

Healthcare and Pharmaceuticals. When it comes to healthcare and pharmaceuticals, cyberattacks can have particularly dire consequences. ” Civil Penalties: A Multi-Factored Analysis Effective August 14, 2009, the CPSC increased the maximum civil penalty to $100,000 per violation and $15 million for a related series of violations.

Manufacturing 40

Manufacturing Compliance Supply Chain Form 40

Frost & Sullivan Manufacturing

DECEMBER 25, 2024

Aligning with Industry Trends: Healthnice Advances Step by Step Amid the global pharmaceutical industry’s evolution, high-end preparations have become a mainstream trend in drug development. Therefore, for pharmaceutical companies, high-end preparations represent a high-value, cost-effective strategy for differentiation.

Pharmaceutical 52

Pharmaceutical Manufacturing Compliance Form 52

Frost & Sullivan Manufacturing

MARCH 28, 2025

In 2009, Yvonne Lungershausen became a Founding Member of CPR Pharma Services (CPR) as it spun out from the University of South Australia. With 30+ years of clinical trial experience gained across most therapeutic areas, Yvonne brings a deep understanding of all phases of the drug development process.

Pharmaceutical 52

Pharmaceutical Compliance Artificial Intelligence Form 52